AA

Akshay Ashok Gupte

Active Director Director DIN 10438314
DIN 10438314 First appointment Dec 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About Akshay Ashok Gupte

Data last updated:

Akshay Ashok Gupte is a Director at Ekviraneuro Healthinstitute Private Limited (since 2023). Ekviraneuro Healthinstitute Private Limited reported revenue of ₹51,522 (FY 2025).

DIN 10438314
Primary Designation Director
First Appointment 26 Dec 2023
Oldest Company Age 2 yrs
Largest company Ekviraneuro Healthinstitute Private Limited · ₹51,522 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Dec 20232023₹51,522 (FY 2025)Active

Board colleagues of Akshay Ashok Gupte

Directorship timeline

Open interactive timeline →
Ekviraneuro Healthinstitute Private Limited
Premium access

Shareholding and investment profile for Akshay Ashok Gupte

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akshay Ashok Gupte

Akshay Ashok Gupte currently holds 1 directorship: Ekviraneuro Healthinstitute Private Limited (Director, since 26 Dec 2023, revenue ₹51,522 (FY 2025)).

Akshay Ashok Gupte was first appointed on 26 Dec 2023 as Director at Ekviraneuro Healthinstitute Private Limited.

The current boards of Akshay Ashok Gupte's companies include Ashok Gupte Kamalakar (Ekviraneuro Healthinstitute Private Limited), Shubhangi Ashok Gupte (Ekviraneuro Healthinstitute Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available